Archives

  • Volume 1, Issue 3, Fall 2025

    • Interstitial Lung Disease in 2025: Updated Classification, Precision Diagnostics, and Expanding Therapeutic Frontiers 
    • Updates in Allergic Bronchopulmonary Aspergillosis
    • Antifibrotics in Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Diseases 
    • Management of Pulmonary Tuberculosis in 2025: An Update for the Respirologist

  • Special Supplement, Fall 2025

    • The Role of Airway Clearance in Managing Chronic Muco‑Obstructive Lung Disease

  • Volume 1, Issue 2, Summer 2025

    • Management of Refractory Chronic Cough and Emerging Therapies in 2025
    • Management of Bronchiectasis for the Community Respirologist
    • The Air We Share: Guiding Inhaler Selection Today for a Sustainable Tomorrow
    • Cardiopulmonary Collaboration in Respiratory Care: Shifting the Paradigm

  • Volume 1, Issue 1, Spring 2025

    • Current Immunotherapies for Lung Cancer: A Review for Respirologists
    • Biologics in the Management of Chronic Obstructive Pulmonary Disease: Emerging Perspective
    • Advances in the Therapy of Eosinophilic Granulomatosis with Polyangiitis (EGPA) in 2025
    • Recommended Vaccinations for Adults: What Respirologists Need to Know
    • De-Escalation of Severe Asthma Therapy: Do We Wean the Biologic or the Inhaler First?